Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Neurocritical Care|March 19, 2014
Aneurysm treatment <24 versus 24-72 h after subarachnoid hemorrhageSimone C Oudshoorn, Gabriel J E Rinkel, Andrew J Molyneux, et al.Human Reproduction (Oxford, England)|September 1, 2017
Ovarian response to controlled ovarian hyperstimulation: what does serum FSH say?Simone C Oudshoorn, Theodora C van Tilborg, Ouijdane Hamdine, et al.Human Reproduction (Oxford, England)|December 16, 2019
Individualized ovarian stimulation in IVF/ICSI treatment: it is time to stop using high FSH doses in predicted low respondersJori A Leijdekkers, Helen L Torrance, Nienke E Schouten, et al.Human Reproduction (Oxford, England)|November 10, 2017
Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responderTheodora C van Tilborg, Helen L Torrance, Simone C Oudshoorn, et al.Human Reproduction (Oxford, England)|May 25, 2019
Cumulative live birth rates in low-prognosis womenJori A Leijdekkers, Marinus J C Eijkemans, Theodora C van Tilborg, et al.Acta Obstetricia Et Gynecologica Scandinavica|May 26, 2019
Do female age and body weight modify the effect of individualized FSH dosing in IVF/ICSI treatment? A secondary analysis of the OPTIMIST trialJori A Leijdekkers, Theodora C van Tilborg, Helen L Torrance, et al.Human Reproduction (Oxford, England)|November 10, 2017
Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysisTheodora C van Tilborg, Simone C Oudshoorn, Marinus J C Eijkemans, et al.Human Reproduction (Oxford, England)|November 10, 2017
Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responderSimone C Oudshoorn, Theodora C van Tilborg, Marinus J C Eijkemans, et al.Pageof 1